Global Piperazine Anhydrous market demonstrates consistent growth momentum, with its valuation reaching USD 63 million in 2023, according to verified industry analysis. Projections indicate steady expansion at a CAGR of 4.50%, with the market expected to achieve USD 85.73 million by 2030. This growth trajectory stems from widening pharmaceutical applications and increasing industrial...